General Information |
|
| NSE Symbol* | REMUS |
| Name of the Company* | REMUS PHARMACEUTICALS LIMITED |
| ISIN* | INE0O5T01011 |
| Type of Meeting |
1) Board Meeting |
| Details of Committee Meeting or Other Type of Meeting | |
| Type of Intimation* | New |
| Reason for Re-schedule (postpone or prepone) / Cancellation | |
| Proposed Meeting Date | 2025-11-10 |
| Original Meeting Date | |
| Whether trading window is closed* | Yes |
| Trading Window Closure- Start date | 2025-10-01 |
| Details of Trading Window Closure End date | 2025-11-12 |
| Short Notice | |
| Date of Report* | 2025-11-01 |
Agenda Details |
|
| Agenda* |
1) Financial results 2) Dividend 3) Other business |
| Whether results are audited or unaudited | Unaudited |
| Nature of report standalone or consolidated | Standalone And Consolidated |
| Period end Type | Half Yearly |
| Period up to (Month) | September |
| Period up to (Year) | 2025 |
| Mode of raising Funds | |
| Type of Dividend |
1) Interim |
| Remarks (website dissemination) | The Company has fixed Friday, November 14, 2025 as the Record Date for reckoning the shareholders who shall be entitled to receive the interim dividend, if any, so declared in the Board Meeting scheduled to be held on November 10, 2025. |